Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

News

Article

April 6, 2024

Derm In The News: March 31-April 6

Author(s):

Keep up with the latest headlines in dermatology from the past week, including the launch of an expanded job board for dermatology support roles, CMS and Incyte's collaboration for povorcitinib in China and Southeast Asia, and more.

KGET: myDermRecruiter Launches Newly Expanded Job Board for Dermatology Support Roles

myDermRecruiter, a recruitment firm in dermatology, has expanded its job board to include a wide range of essential support roles within dermatology practices. The expansion aims to meet the increasing demand for professionals in roles such as dermatology medical assistants, office managers, instrument techs, and research coordinators. For more information, contact JobBoard@myDermRecruiter.com.

Patient-Forward Rundown

Top headlines from this week to share with your patients:

Yahoo Finance: CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia

Incyte and China Medical System Holdings Limited have entered a collaboration to develop and commercialize povorcitinib for various dermatologic diseases in Mainland China, Hong Kong, Macao, Taiwan, and certain Southeast Asian countries. The agreement grants CMS an exclusive license to develop and commercialize povorcitinib in autoimmune and inflammatory dermatologic diseases, including non-segmental vitiligo, hidradenitis suppurativa, prurigo nodularis, and chronic spontaneous urticaria.

We covered this news! Read more here.

Good Morning America: Teen refugee starts cosmetics company to be inclusive to all skin tones

Kavya Odari, a Nepalese refugee who moved to the US at 3 years old, founded K.O. Cosmetics in 2020, driven by her own experiences of being bullied for her culture and appearance. Her brand aims to provide inclusive beauty products for all skin tones and types.

Cronkite News: FDA considers updating pulse oximeter guidelines to make readings on dark skin more accurate

The FDA is considering updating its 2013 premarket guidance for pulse oximeter manufacturers due to research indicating inaccuracies in readings for patients with dark skin. Studies show that pulse oximeters may overestimate blood oxygen levels for these patients, leading to incorrect diagnoses and treatments. Attorneys general from 24 states, including Arizona, urged the FDA to take action, proposing clear warning labels for reduced effectiveness based on skin tone.

Have you seen any dermatology headlines this week that we may have missed? Share with us by emailing our team at DTEditor@mmhgroup.com.